ABOUT POLYADVANT
Built on chemistry.
Focused on cancer.
A biotechnology company translating radiation-responsive chemistry into investigational precision oncology therapeutics.
WHO WE ARE
From scientific concept
to therapeutic candidate.
PolyAdvant Pharmaceutical is a Shenzhen-based biotechnology company focused on radiotherapy-activated therapeutics for oncology.
Founded in 2021 and incubated from research at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, the company brings together polymer chemistry, chemical biology and drug delivery expertise.
OUR PURPOSE
To make drug activation
as precise as the treatment beam.
Our mission is to develop medicines that use radiotherapy as an activation signal, exploring localized payload release and new approaches to combined radiation and drug treatment.
Chemistry can add a new layer of control to radiotherapy.POLYADVANT'S SCIENTIFIC VISION
OUR JOURNEY
Science translated
with purpose.
The company was created to advance a foundational discovery in radiation-mediated prodrug activation toward therapeutic development.
WORK WITH US
Connect science, development and opportunity.
Hello, World!